We are looking at somewhere between $300 million to $400 million of revenue down the road if everything executes correctly. The challenge will be that we have already received one acquisition offer, which we've declined. At some point an offer is going to come in that's difficult to decline.
In my mind, there's no question that five to 10 years from now what we are doing in terms of diagnostics is going to be standard practice. As long as we keep moving, stay first, and stay agile, then we will own that space, and that is literally hundreds and hundreds of millions of dollars in potential revenue.